Patents Assigned to Nikken Sohonsha Corporation
-
Patent number: 11963485Abstract: A natural invasion promoting method that is environmentally friendly, easy to carry out, can cope with a wide range of areas and inclined surfaces, achieves efficient natural invasion, and can satisfactorily promote greening on a soil surface of interest, and a spraying material used in the method are provided. A natural invasion promoting method including: spraying a spraying material containing live algae on a soil surface; breeding the live algae; and also directly or indirectly catching flying seeds or spores by a tacky substance secreted on surfaces of the live algae or a catching structure composed of the live algae to promote greening on the soil surface.Type: GrantFiled: August 14, 2019Date of Patent: April 23, 2024Assignees: NIPPON KOEI CO., LTD., NIKKEN SOHONSHA CORPORATIONInventors: Mineto Tomisaka, Masaru Onodera, Fumiko Iwaki, Hisako Sanada, Taketo Nakano, Nobuo Mori, Ryo Sumi, Kanya Tokunaga
-
Publication number: 20220046868Abstract: A natural invasion promoting method that is environmentally friendly, easy to carry out, can cope with a wide range of areas and inclined surfaces, achieves efficient natural invasion, and can satisfactorily promote greening on a soil surface of interest, and a spraying material used in the method are provided. A natural invasion promoting method including: spraying a spraying material containing live algae on a soil surface; breeding the live algae; and also directly or indirectly catching flying seeds or spores by a tacky substance secreted on surfaces of the live algae or a catching structure composed of the live algae to promote greening on the soil surface.Type: ApplicationFiled: August 14, 2019Publication date: February 17, 2022Applicants: NIPPON KOEI CO., LTD., NIKKEN SOHONSHA CORPORATIONInventors: Mineto TOMISAKA, Masaru ONODERA, Fumiko IWAKI, Hisako SANADA, Taketo NAKANO, Nobuo MORI, Ryo SUMI, Kanya TOKUNAGA
-
Patent number: 9180152Abstract: The invention is a method for treating psoriasis in a subject suffering from psoriasis. The method includes orally administering to the subject a pharmaceutically-effective amount of crude Dunaliella powder.Type: GrantFiled: December 5, 2010Date of Patent: November 10, 2015Assignees: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv Shaish, Dror Harats, Shoshana Greenberger
-
Patent number: 8961993Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: GrantFiled: July 18, 2013Date of Patent: February 24, 2015Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Patent number: 8722057Abstract: In a step of producing a powder product of the alga belonging to the genus Dunaliella, a pH adjusting step is included in which an alga belonging to the genus Dunaliella is allowed to be in a basic state of pH 9.5 or higher. According to the method, it is possible to provide dried Dunaliella powder containing ?-carotene at a high content by suppressing degradation of ?-carotene as an active ingredient while decreasing each of the total pheophorbide amount and the existing pheophorbide amount to a predetermined value or less, even if the total pheophorbide amount and the existing pheophorbide amount of the cultured algae belonging to the genus Dunaliella are higher in summer.Type: GrantFiled: May 2, 2012Date of Patent: May 13, 2014Assignee: Nikken Sohonsha CorporationInventors: Ami Ben-Amotz, Nobuo Mori
-
Publication number: 20140023702Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: ApplicationFiled: July 18, 2013Publication date: January 23, 2014Applicants: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., NIKKEN SOHONSHA CORPORATIONInventors: Michael BELKIN, Aviv SHAISH, Dror HARATS, Ygal ROTENSTREICH
-
Patent number: 8529907Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: GrantFiled: April 27, 2009Date of Patent: September 10, 2013Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Patent number: 8343549Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: May 11, 2010Date of Patent: January 1, 2013Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Publication number: 20120288519Abstract: In a step of producing a powder product of the alga belonging to the genus Dunaliella, a pH adjusting step is included in which an alga belonging to the genus Dunaliella is allowed to be in a basic state of pH 9.5 or higher. According to the method, it is possible to provide dried Dunaliella powder containing ?-carotene at a high content by suppressing degradation of ?-carotene as an active ingredient while decreasing each of the total pheophorbide amount and the existing pheophorbide amount to a predetermined value or less, even if the total pheophorbide amount and the existing pheophorbide amount of the cultured algae belonging to the genus Dunaliella are higher in summer.Type: ApplicationFiled: May 2, 2012Publication date: November 15, 2012Applicant: NIKKEN SOHONSHA CORPORATIONInventors: Ami BEN-AMOTZ, Nobuo MORI
-
Publication number: 20110045035Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: ApplicationFiled: April 27, 2009Publication date: February 24, 2011Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SEVICES LTD.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Patent number: 7790175Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.Type: GrantFiled: July 28, 2006Date of Patent: September 7, 2010Assignee: Nikken Sohonsha CorporationInventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
-
Publication number: 20100221348Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: ApplicationFiled: May 11, 2010Publication date: September 2, 2010Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv SHAISH, Dror HARATS
-
Patent number: 7763255Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: July 10, 2007Date of Patent: July 27, 2010Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Publication number: 20100047269Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.Type: ApplicationFiled: July 28, 2006Publication date: February 25, 2010Applicant: NIKKEN SOHONSHA CORPORATIONInventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
-
Publication number: 20080019997Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: ApplicationFiled: July 10, 2007Publication date: January 24, 2008Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv Shaish, Dror Harats
-
Patent number: 7264813Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: September 24, 2003Date of Patent: September 4, 2007Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Patent number: 5948823Abstract: A method of protecting a mammal from the detrimental effects of irradiation is disclosed. The method comprises administering an effective amount of a substantially crude Dunaliella algae preparation to the mammal.Type: GrantFiled: September 9, 1997Date of Patent: September 7, 1999Assignees: Hadasit Medical Research Services & Development Company Ltd., Nikken Sohonsha CorporationInventors: Ami Ben-Amotz, Zeev Weshler, Shaul Yatziv, Mordechai Sela